Description                                            
Breast cancer is a disease of very high mortality. More than 50,000 women die of breast cancer every year in India. In Indian women, breast cancer is the second most common cancer, next only to carcinoma cervix. But in many urban areas in India, the breast cancer has recently emerged as the leading cancer in women. Breast cancer will become most common cancer among Indian women by 2020. Breast cancer constitutes about 28% of all cancer cases among women in India. The market is growing significantly over the last few years. The pharmacological management market of breast cancer is expected to become more than an INR 10,000 millions market by the year 2016. The major constituents of this market are anticancer drugs and chemotherapeutic agents. Apart from these the breast cancer management includes radiotherapy and surgical procedure too.                                            
                                            
                                            
Scope:                                            

• Breast Cancer Market                                             
• Treatment Options in India                                            
• Key Drivers and Challenges in Indian Market                                            
• Competitive Landscape   
                                         

Key Benefits:                                            

• Key drivers and barriers                                            
• Market Forecast with Macroeconomic Assumptions                                            
• Regulatory and Legal Framework in India                                            
• Key players in India